BPTH (Bio-Path Holdings) Other Current Liabilities: $0.46 Mil (As of Mar. 2026)


What is Bio-Path Holdings Other Current Liabilities?

Bio-Path Holdings BPTH +34.29% Other Current Liabilities is $0.46 Mil as of Mar. 2026. The stock has 1 warning sign investors should review.

Bio-Path Holdings's other current liabilities for the quarter that ended in Mar. 2026 was $0.46 Mil.

Bio-Path Holdings's quarterly other current liabilities increased from Jun. 2025 ($0.00 Mil) to Sep. 2025 ($0.34 Mil) and increased from Sep. 2025 ($0.34 Mil) to Mar. 2026 ($0.46 Mil).

Bio-Path Holdings's annual other current liabilities increased from Dec. 2022 ($-0.00 Mil) to Dec. 2023 ($0.00 Mil) but then declined from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($-0.00 Mil).

Bio-Path Holdings Other Current Liabilities Related Terms

Bio-Path Holdings Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Bio-Path Holdings's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Path Holdings Other Current Liabilities Chart

Bio-Path Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.00 0.00 -0.00

Bio-Path Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 -0.00 0.00 0.34 0.46

Bio-Path Holdings Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0.46 Mil mean?
Bio-Path Holdings (BPTH) has a Other Current Liabilities of $0.46 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Bio-Path Holdings.
Is Bio-Path Holdings' Other Current Liabilities too high?
Bio-Path Holdings' current Other Current Liabilities is $0.46 Mil.
How does Bio-Path Holdings' Other Current Liabilities compare to VBIO and HEPA?
Bio-Path Holdings' Other Current Liabilities of $0.46 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Bio-Path Holdings. Bio-Path Holdings's current Other Current Liabilities is $0.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Path Holdings stock overvalued right now?
Bio-Path Holdings (BPTH) has a current Other Current Liabilities of $0.46 Mil. The current Other Current Liabilities is $0.46 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Bio-Path Holdings (BPTH), the current Other Current Liabilities is $0.46 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bio-Path Holdings Business Description

Address No. 2407, 625 Stanwix Street, Pittsburgh, PA, USA, 15222
Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of a Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE.